GH
Guardant Health, Inc.
Key Financials
Net Income
$-416277000
↑ 4.6%
Revenue
$982.0M
↑ 32.9%
Operating Income
$-437248000
↑ 1.4%
EPS (Diluted)
$-3.32
↑ 6.7%
Total Liabilities
$2.1B
↑ 30.0%
Shareholders' Equity
$-99307000.00
↑ 28.9%
Total Assets
$2.0B
↑ 35.5%
Cash & Equivalents
$378.2M
↓ 28.0%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 7/2/2026 | View on SEC |
| 4 | 7/2/2026 | View on SEC |
| 4 | 7/2/2026 | View on SEC |
| 4 | 7/2/2026 | View on SEC |
| 4 | 7/2/2026 | View on SEC |
| 4 | 7/2/2026 | View on SEC |
| 4 | 7/2/2026 | View on SEC |
| 4 | 7/2/2026 | View on SEC |
| 4 | 7/2/2026 | View on SEC |
| 144 | 7/1/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | GH |
| Company Name | Guardant Health, Inc. |
| CIK | 1576280 |
| Sector | Services-Medical Laboratories |
| Industry | Large accelerated filer |
| Exchange | Nasdaq |
| SIC Code | 8071 |
| SIC Description | Services-Medical Laboratories |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 855-698-8887 |